Stryker (NYSE:SYK) is taking its time getting the Mako robot-assisted Triathlon total knee device on the market, despite having won FDA approval last August. Admitting that the integration of Mako after the $1.7 billion acquisition in December 2013 was “messy,” CEO Kevin Lobo said Stryker isn’t planning to launch the total knee offering until 2017. […]
Stryker (NYSE:SYK) said yesterday that it won 510(k) clearance from the FDA for a total knee tool for the Mako Surgical robot-assisted surgery platform it bought in 2013. Stryker now has Mako-compatible offerings for total and partial knee replacement and total hip replacement, the company said. “The ability to include a Mako total knee application with our market leading […]
October 16, 2014 by Brian Johnson
Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.